Cognitive enhancement

Cognitive enhancement — also called neuroenhancement — refers to any deliberate attempt to improve one or more cognitive functions above a person's own rested, healthy baseline. Attention, working memory, processing speed, and executive control are the domains most often targeted. The concept draws a meaningful line between restoration (returning an impaired system toward normal) and enhancement proper (raising a ceiling that was already intact). Most pharmacological evidence supports the former; the latter is far harder to demonstrate.

The term covers stimulant drugs, wakefulness agents, racetams, and a broad range of marketed nootropics, as well as non-drug approaches such as transcranial stimulation. On substance pages it almost always refers to drugs taken by healthy people in academic, professional, or recreational contexts — a practice loosely called smart-drug use.

How it works · its role

Cognitive performance is not a single dimension. Attention, memory consolidation, verbal fluency, and processing speed each depend on different circuits and different neurochemical balances, so a substance that sharpens one function can leave another untouched — or actively trade off against it.

A central feature of the literature is the inverted-U relationship between arousal and prefrontal performance. Moderate increases in dopamine and norepinephrine improve working memory and impulse control; too much degrades them. This means people who are fatigued, sleep-deprived, or have attention deficits tend to sit on the left side of the curve, where a stimulant provides a real lift. People already operating near their optimal arousal may gain little, or push past it into impaired territory.

Expectation and alertness account for a further slice of the apparent effect. A drug that produces a felt sense of focus can improve performance on simple, sustained-attention tasks without moving higher cognitive metrics at all — a distinction that controlled studies regularly surface.

Relevance to substances & effects

Stimulants are the most studied class. Amphetamines and methylphenidate reliably reduce fatigue and improve sustained attention; meta-analyses of healthy adults find that gains on complex cognitive tasks are modest and inconsistent, and often disappear under well-controlled conditions. Modafinil shows a similar pattern — the clearest benefit appears in the sleep-deprived rather than in those who are simply rested.

Caffeine improves alertness and simple reaction time robustly and reproducibly. Its effect on higher cognition is smaller and strongly context-dependent. Racetams and most marketed nootropic compounds have little controlled human evidence in healthy adults; effects are generally negligible or indistinguishable from placebo.

Subjective confidence that a substance is enhancing performance is itself a documented effect of stimulants and modafinil, and it tracks poorly with objective measurement. The gap between felt enhancement and measured enhancement is one of the most practically relevant facts about this category — and explains why anecdotal accounts tend to outrun what trials find.